IMMUNOGENIC TARGETING

Brand	Owner	Address	Description
IMMUNOTARGETING	Acceptys, Inc.	3960 Broadway New York NY 10032	IMMUNOGENIC TARGETING;Process by which antibodies are utilized to identify, or target immunogenic materials that may then be used to develop therapies;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

A high molecular weight polysaccharide intracellular adhesin (SAE) antigen having the general structure of poly-1,6,?-2-amidoglucopyranoside, which is variable substituted with N-acetyl and O-succinyl substituents is described. Also, a method is given for isolating this antigen from Staphylococcus aureus. The SAE can be used in a vaccine, either alone, conjugated to an immunogenic protein, and/or with an immunogenic adjuvant.